标题
Anti-Angiogenic Therapy: Current Challenges and Future Perspectives
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 7, Pages 3765
出版商
MDPI AG
发表日期
2021-04-05
DOI
10.3390/ijms22073765
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- New advances in antiangiogenic combination therapeutic strategies for advanced non-small cell lung cancer
- (2020) Huiping Qiang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Clinical efficacy and safety of anti-PD-1/PD-L1 inhibitors for the treatment of advanced or metastatic cancer: a systematic review and meta-analysis
- (2020) Leitao Sun et al. Scientific Reports
- Monocytes as Endothelial Progenitor Cells (EPCs), Another Brick in the Wall to Disentangle Tumor Angiogenesis
- (2020) Filipa Lopes-Coelho et al. Cells
- Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma
- (2020) Antonella Argentiero et al. Journal of Clinical Medicine
- NRF2 preserves genomic integrity by facilitating ATR activation and G2 cell cycle arrest
- (2020) Xiaohui Sun et al. NUCLEIC ACIDS RESEARCH
- Catecholamines in the regulation of angiogenesis in cutaneous wound healing
- (2020) Debanjan Chakroborty et al. FASEB JOURNAL
- Immunotherapy combinations for the treatment of patients with solid tumors
- (2020) Maria Virginia Bluthgen et al. Future Oncology
- Vanucizumab mode of action: Serial biomarkers in plasma, tumor, and skin-wound-healing biopsies
- (2020) Florian Heil et al. Translational Oncology
- Safety and Tolerability of Anti-Angiogenic Protein Kinase Inhibitors and Vascular-Disrupting Agents in Cancer: Focus on Gastrointestinal Malignancies
- (2019) Letizia Procaccio et al. DRUG SAFETY
- Structure Analysis and Anti-Tumor and Anti-Angiogenic Activities of Sulfated Galactofucan Extracted from Sargassum thunbergii
- (2019) Weihua Jin et al. Marine Drugs
- Ponatinib: a novel multi-tyrosine kinase inhibitor against human malignancies
- (2019) Fiona H Tan et al. OncoTargets and Therapy
- Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
- (2019) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ropivacaine inhibits tumor angiogenesis via sodium-channel-independent mitochondrial dysfunction and oxidative stress
- (2019) Jingwen Yang et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment
- (2019) Ming Yi et al. Molecular Cancer
- Potential Applications of NRF2 Inhibitors in Cancer Therapy
- (2019) Emiliano Panieri et al. Oxidative Medicine and Cellular Longevity
- Cediranib suppresses homology-directed DNA repair through down-regulation of BRCA1/2 and RAD51
- (2019) Alanna R. Kaplan et al. Science Translational Medicine
- Catecholamines contribute to the neovascularization of lung cancer via tumor-associated macrophages
- (2019) Yun Xia et al. BRAIN BEHAVIOR AND IMMUNITY
- Impact of hypoxia on DNA repair and genome integrity
- (2019) Alanna R Kaplan et al. MUTAGENESIS
- Exploring the Immunological Mechanisms Underlying the Anti-vascular Endothelial Growth Factor Activity in Tumors
- (2019) Rodrigo Barbosa de Aguiar et al. Frontiers in Immunology
- Role of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis
- (2019) Gandhi T. K. Boopathy et al. Frontiers in Cell and Developmental Biology
- Prognostic role of the beta-2 adrenergic receptor in clear cell renal cell carcinoma
- (2019) Mihyang Ha et al. Animal Cells and Systems
- A phase I study of the PARP inhibitor niraparib in combination with bevacizumab in platinum-sensitive epithelial ovarian cancer: NSGO AVANOVA1/ENGOT-OV24
- (2019) Mansoor Raza Mirza et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- PD-L1 Distribution and Perspective for Cancer Immunotherapy—Blockade, Knockdown, or Inhibition
- (2019) Yilun Wu et al. Frontiers in Immunology
- Vasculogenic Mimicry: Become an Endothelial Cell “But Not So Much”
- (2019) Mónica Fernández-Cortés et al. Frontiers in Oncology
- THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Catalytic receptors
- (2019) Stephen P H Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours
- (2019) Robin L. Jones et al. EUROPEAN JOURNAL OF CANCER
- Tumor vasculature remolding by thalidomide increases delivery and efficacy of cisplatin
- (2019) Yanwei Shen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial
- (2019) Mansoor Raza Mirza et al. LANCET ONCOLOGY
- PARP Inhibition in Cancer: An Update on Clinical Development
- (2019) Esha Sachdev et al. Targeted Oncology
- The balance between NRF2/GSH antioxidant mediated pathway and DNA repair modulates cisplatin resistance in lung cancer cells
- (2019) Matheus Molina Silva et al. Scientific Reports
- Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements
- (2019) Vaishali Aggarwal et al. Biomolecules
- Redox-Mediated Mechanism of Chemoresistance in Cancer Cells
- (2019) Eun-Kyung Kim et al. Antioxidants
- Discovery of arylamide-5-anilinoquinazoline-8-nitro derivatives as VEGFR-2 kinase inhibitors: Synthesis, in vitro biological evaluation and molecular docking
- (2019) Yongqiang Zhao et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Use of Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer
- (2019) Jianchun Duan et al. JAMA Oncology
- Consensus guidelines for the use and interpretation of angiogenesis assays
- (2018) Patrycja Nowak-Sliwinska et al. ANGIOGENESIS
- Beta-adrenergic signaling on neuroendocrine differentiation, angiogenesis, and metastasis in prostate cancer progression
- (2018) Wenliang Li et al. ASIAN JOURNAL OF ANDROLOGY
- Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa
- (2018) Kabir A. Khan et al. Nature Reviews Clinical Oncology
- VEGF-C sustains VEGFR2 activation under bevacizumab therapy and promotes glioblastoma maintenance
- (2018) Signe R Michaelsen et al. NEURO-ONCOLOGY
- Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
- (2018) Mark A. Socinski et al. NEW ENGLAND JOURNAL OF MEDICINE
- ROS signalling in the biology of cancer
- (2018) Jennifer N. Moloney et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Endothelial Cell Metabolism in Health and Disease
- (2018) Katerina Rohlenova et al. TRENDS IN CELL BIOLOGY
- Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases
- (2018) Maria Angela Incalza et al. VASCULAR PHARMACOLOGY
- Tumor angiogenesis and anti‑angiogenic gene therapy for cancer (Review)
- (2018) Tinglu Li et al. Oncology Letters
- The possible existence of occult metastasis in patients with ovarian clear-cell carcinoma who underwent complete resection without any residual tumours
- (2018) Hiroaki Kajiyama et al. Oncotarget
- Pigment Epithelium-Derived Factor (PEDF) as a Regulator of Wound Angiogenesis
- (2018) Elizabeth R. Michalczyk et al. Scientific Reports
- PDGF-mediated mesenchymal transformation renders endothelial resistance to anti-VEGF treatment in glioblastoma
- (2018) Tianrun Liu et al. Nature Communications
- Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
- (2018) Spencer C. Wei et al. Cancer Discovery
- Comprehensive review on how platinum- and taxane-based chemotherapy of ovarian cancer affects biology of normal cells
- (2018) Justyna Mikuła-Pietrasik et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- ROS and the DNA damage response in cancer
- (2018) Upadhyayula Sai Srinivas et al. Redox Biology
- Potential Contributions of Antioxidants to Cancer Therapy: Immunomodulation and Radiosensitization
- (2017) Anita Thyagarajan et al. INTEGRATIVE CANCER THERAPIES
- Palmitic acid dysregulates the Hippo–YAP pathway and inhibits angiogenesis by inducing mitochondrial damage and activating the cytosolic DNA sensor cGAS–STING–IRF3 signaling mechanism
- (2017) Liangshuai Yuan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ROS-modulated therapeutic approaches in cancer treatment
- (2017) Muhammad Hassan Raza et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Onartuzumab Plus Bevacizumab Versus Placebo Plus Bevacizumab in Patients With Recurrent Glioblastoma: Efficacy, Safety, and Hepatocyte Growth Factor and O6-Methylguanine–DNA Methyltransferase Biomarker Analyses
- (2017) Timothy Cloughesy et al. JOURNAL OF CLINICAL ONCOLOGY
- Baicalein inhibits tumor progression by inhibiting tumor cell growth and tumor angiogenesis
- (2017) Yang-Gyu Park et al. ONCOLOGY REPORTS
- Endothelial progenitor cells for cellular angiogenesis and repair: lessons learned from experimental animal models
- (2017) Khawaja Husnain Haider et al. Regenerative Medicine
- Adrenergic nerves activate an angio-metabolic switch in prostate cancer
- (2017) Ali H. Zahalka et al. SCIENCE
- Vascular Mimicry: A Novel Neovascularization Mechanism Driving Anti-Angiogenic Therapy (AAT) Resistance in Glioblastoma
- (2017) Kartik Angara et al. Translational Oncology
- Catecholamines facilitate VEGF-dependent angiogenesis via β2-adrenoceptor-induced Epac1 and PKA activation
- (2017) Jaspal Garg et al. Oncotarget
- PDGF Family Expression in Glioblastoma Multiforme: Data Compilation from Ivy Glioblastoma Atlas Project Database
- (2017) Isabella Gomes Cantanhede et al. Scientific Reports
- Controversy about pharmacological modulation of Nrf2 for cancer therapy
- (2017) Lidija Milkovic et al. Redox Biology
- Ponatinib: A Review of Efficacy and Safety
- (2017) Fulvio Massaro et al. CURRENT CANCER DRUG TARGETS
- Anthelmintic drug ivermectin inhibits angiogenesis, growth and survival of glioblastoma through inducing mitochondrial dysfunction and oxidative stress
- (2016) Yingying Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects
- (2016) Dong Li et al. CANCER LETTERS
- Ivermectin Induces Cytostatic Autophagy by Blocking the PAK1/Akt Axis in Breast Cancer
- (2016) Q. Dou et al. CANCER RESEARCH
- Angiopoietin-Tie signalling in the cardiovascular and lymphatic systems
- (2016) L. Eklund et al. CLINICAL SCIENCE
- Anti-tumor effects of pigment epithelium-derived factor (PEDF): implication for cancer therapy. A mini-review
- (2016) Louiza Belkacemi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Ponatinib reduces viability, migration, and functionality of human endothelial cells
- (2016) Ayala Gover-Proaktor et al. LEUKEMIA & LYMPHOMA
- Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases
- (2016) Sophia Frentzas et al. NATURE MEDICINE
- Beta-adrenergic signaling promotes tumor angiogenesis and prostate cancer progression through HDAC2-mediated suppression of thrombospondin-1
- (2016) M Hulsurkar et al. ONCOGENE
- The Antioxidative Fraction of White Mulberry Induces Apoptosis through Regulation of p53 and NFκB in EAC Cells
- (2016) AHM Khurshid Alam et al. PLoS One
- Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages
- (2016) Teresa E. Peterson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival
- (2016) Jonas Kloepper et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The ROS-mediated activation of STAT-3/VEGF signaling is involved in the 27-hydroxycholesterol-induced angiogenesis in human breast cancer cells
- (2016) Dongmei Zhu et al. TOXICOLOGY LETTERS
- Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma
- (2016) Jeffrey J. Wallin et al. Nature Communications
- Brusatol inhibits HIF-1 signaling pathway and suppresses glucose uptake under hypoxic conditions in HCT116 cells
- (2016) Yapeng Lu et al. Scientific Reports
- An oxidative DNA “damage” and repair mechanism localized in the VEGF promoter is important for hypoxia-induced VEGF mRNA expression
- (2015) Viktor Pastukh et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Endostatin's emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications
- (2015) Amit Walia et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- PEDF and its roles in physiological and pathological conditions: implication in diabetic and hypoxia-induced angiogenic diseases
- (2015) Xuemin He et al. CLINICAL SCIENCE
- Combined therapy with thrombospondin-1 type I repeats (3TSR) and chemotherapy induces regression and significantly improves survival in a preclinical model of advanced stage epithelial ovarian cancer
- (2015) Samantha Russell et al. FASEB JOURNAL
- Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity—implications for therapeutic targeting of Nrf2
- (2015) Adedamola Olayanju et al. FREE RADICAL BIOLOGY AND MEDICINE
- Nrf2 facilitates repair of radiation induced DNA damage through homologous recombination repair pathway in a ROS independent manner in cancer cells
- (2015) Sundarraj Jayakumar et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Modulation of P2X4/P2X7/Pannexin-1 sensitivity to extracellular ATP via Ivermectin induces a non-apoptotic and inflammatory form of cancer cell death
- (2015) Dobrin Draganov et al. Scientific Reports
- Compensatory angiogenesis and tumor refractoriness
- (2015) R N Gacche Oncogenesis
- Beta-Blocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival
- (2015) Oncotarget
- Plasticity in Tumor-Promoting Inflammation: Impairment of Macrophage Recruitment Evokes a Compensatory Neutrophil Response
- (2015) Jessica C. Pahler et al. NEOPLASIA
- Biologic Effects of Dopamine on Tumor Vasculature in Ovarian Carcinoma
- (2015) Myrthala Moreno-Smith et al. NEOPLASIA
- Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions
- (2014) Naveen S. Vasudev et al. ANGIOGENESIS
- Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
- (2014) Rakesh K. Jain CANCER CELL
- Deferoxamine Promotes MDA-MB-231 Cell Migration and Invasion through Increased ROS-Dependent HIF-1a Accumulation
- (2014) Yiping Liu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Adrenergic signaling promotes angiogenesis through endothelial cell-tumor cell crosstalk
- (2014) H. Chen et al. ENDOCRINE-RELATED CANCER
- β-Blockers Promote Angiogenesis in the Mouse Aortic Ring Assay
- (2014) Tonino Stati et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Phase II trial of triple tyrosine kinase receptor inhibitor nintedanib in recurrent high-grade gliomas
- (2014) Andrew D. Norden et al. JOURNAL OF NEURO-ONCOLOGY
- Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study
- (2014) Joyce F Liu et al. LANCET ONCOLOGY
- Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
- (2014) Hansjochen Wilke et al. LANCET ONCOLOGY
- Differential Antitumor Activity of Aflibercept and Bevacizumab in Patient-Derived Xenograft Models of Colorectal Cancer
- (2014) M. Chiron et al. MOLECULAR CANCER THERAPEUTICS
- Role of Angiopoietin-2 in Adaptive Tumor Resistance to VEGF Signaling Blockade
- (2014) Nicolò Rigamonti et al. Cell Reports
- Combination therapy with carboplatin and thalidomide suppresses tumor growth and metastasis in 4T1 murine breast cancer model
- (2013) Cristina Maria de Souza et al. BIOMEDICINE & PHARMACOTHERAPY
- β-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma
- (2013) E Pasquier et al. BRITISH JOURNAL OF CANCER
- A Core Human Primary Tumor Angiogenesis Signature Identifies the Endothelial Orphan Receptor ELTD1 as a Key Regulator of Angiogenesis
- (2013) Massimo Masiero et al. CANCER CELL
- Tumor resistance to anti-VEGF therapy through up-regulation of VEGF-C expression
- (2013) Dong Li et al. CANCER LETTERS
- Gene Expression Profile Identifies Tyrosine Kinase c-Met as a Targetable Mediator of Antiangiogenic Therapy Resistance
- (2013) A. Jahangiri et al. CLINICAL CANCER RESEARCH
- Targeting FGFR with Dovitinib (TKI258): Preclinical and Clinical Data in Breast Cancer
- (2013) F. Andre et al. CLINICAL CANCER RESEARCH
- Endothelial NO synthase and reactive oxygen species mediated effect of simvastatin on vessel structure and function: Pleiotropic and dose-dependent effect on tumor vascular stabilization
- (2013) YESHAN CHEN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Vitamin C suppresses cell death in MCF-7 human breast cancer cells induced by tamoxifen
- (2013) Tamilselvan Subramani et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Randomized Phase III Trial of Temsirolimus and Bevacizumab Versus Interferon Alfa and Bevacizumab in Metastatic Renal Cell Carcinoma: INTORACT Trial
- (2013) Brian I. Rini et al. JOURNAL OF CLINICAL ONCOLOGY
- S49076 Is a Novel Kinase Inhibitor of MET, AXL, and FGFR with Strong Preclinical Activity Alone and in Association with Bevacizumab
- (2013) M. F. Burbridge et al. MOLECULAR CANCER THERAPEUTICS
- The Association of Alternate VEGF Ligands with Resistance to Anti-VEGF Therapy in Metastatic Colorectal Cancer
- (2013) Christopher H. Lieu et al. PLoS One
- Multifarious functions of PDGFs and PDGFRs in tumor growth and metastasis
- (2013) Yihai Cao TRENDS IN MOLECULAR MEDICINE
- Human Endothelial Progenitor Cells
- (2013) M. C. Yoder Cold Spring Harbor Perspectives in Medicine
- Neuropilin 1 guides regulatory T cells into VEGF-producing melanoma
- (2013) Wiebke Hansen OncoImmunology
- Propranolol Induces Regression of Hemangioma Cells Through HIF-1α–Mediated Inhibition of VEGF-A
- (2012) Harvey Chim et al. ANNALS OF SURGERY
- Thalidomide attenuates mammary cancer associated-inflammation, angiogenesis and tumor growth in mice
- (2012) Cristina Maria de Souza et al. BIOMEDICINE & PHARMACOTHERAPY
- VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2
- (2012) N G Gavalas et al. BRITISH JOURNAL OF CANCER
- VEGF Inhibits Tumor Cell Invasion and Mesenchymal Transition through a MET/VEGFR2 Complex
- (2012) Kan V. Lu et al. CANCER CELL
- VEGFA-VEGFR Pathway Blockade Inhibits Tumor-Induced Regulatory T-cell Proliferation in Colorectal Cancer
- (2012) M. Terme et al. CANCER RESEARCH
- Identification of Pigment Epithelium-Derived Factor Protein Forms with Distinct Activities on Tumor Cell Lines
- (2012) P. Subramanian et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Neuropilin 1 deficiency on CD4+Foxp3+regulatory T cells impairs mouse melanoma growth
- (2012) Wiebke Hansen et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Systematic review and meta-analysis of Endostar (rh-endostatin) combined with chemotherapy versus chemotherapy alone for treating advanced non-small cell lung cancer
- (2012) Rong Biaoxue et al. World Journal of Surgical Oncology
- The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis
- (2011) Weon-Kyoo You et al. BMB Reports
- Angiopoietin-1 and -2 Exert Antagonistic Functions in Tumor Angiogenesis, yet Both Induce Lymphangiogenesis
- (2011) E. Fagiani et al. CANCER RESEARCH
- Regulation of pancreatic cancer by neuropsychological stress responses: a novel target for intervention
- (2011) H. M. Schuller et al. CARCINOGENESIS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Cancer cells metabolically "fertilize" the tumor microenvironment with hydrogen peroxide, driving the Warburg effect
- (2011) Ubaldo E. Martinez-Outschoorn et al. CELL CYCLE
- Placental Growth Factor Upregulation Is a Host Response to Antiangiogenic Therapy
- (2011) R. G. Bagley et al. CLINICAL CANCER RESEARCH
- Brivanib, a Dual FGF/VEGF Inhibitor, Is Active Both First and Second Line against Mouse Pancreatic Neuroendocrine Tumors Developing Adaptive/Evasive Resistance to VEGF Inhibition
- (2011) Elizabeth Allen et al. CLINICAL CANCER RESEARCH
- Anti-angiogenic properties of carnosol and carnosic acid, two major dietary compounds from rosemary
- (2011) Auxiliadora López-Jiménez et al. EUROPEAN JOURNAL OF NUTRITION
- Beta Blockers and Breast Cancer Mortality: A Population- Based Study
- (2011) Thomas I. Barron et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting the Angiopoietin/Tie2 Pathway: Cutting Tumor Vessels With a Double-Edged Sword?
- (2011) Tina Cascone et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of adrenaline in human colon adenocarcinoma HT-29 cells
- (2011) Helen P.S. Wong et al. LIFE SCIENCES
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
- (2011) Peter Carmeliet et al. NATURE REVIEWS DRUG DISCOVERY
- Baicalein inhibits oxidative stress-induced cellular damage via antioxidant effects
- (2011) Kyoung Ah Kang et al. TOXICOLOGY AND INDUSTRIAL HEALTH
- A Phase 1 Trial of ABT-510 Concurrent With Standard Chemoradiation for Patients With Newly Diagnosed Glioblastoma
- (2010) Louis B. Nabors et al. ARCHIVES OF NEUROLOGY
- Social isolation is associated with elevated tumor norepinephrine in ovarian carcinoma patients
- (2010) Susan K. Lutgendorf et al. BRAIN BEHAVIOR AND IMMUNITY
- Identification of serum angiopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapy
- (2010) V Goede et al. BRITISH JOURNAL OF CANCER
- HGF/c-Met Acts as an Alternative Angiogenic Pathway in Sunitinib-Resistant Tumors
- (2010) F. Shojaei et al. CANCER RESEARCH
- FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer
- (2010) N. Turner et al. CANCER RESEARCH
- Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease
- (2010) Sara Van de Veire et al. CELL
- Resveratrol attenuates the anticancer efficacy of paclitaxel in human breast cancer cells in vitro and in vivo
- (2010) Masayuki Fukui et al. EUROPEAN JOURNAL OF CANCER
- Regulatory T cells in tumor immunity
- (2010) Hiroyoshi Nishikawa et al. INTERNATIONAL JOURNAL OF CANCER
- Norepinephrine induces VEGF expression and angiogenesis by a hypoxia-inducible factor-1α protein-dependent mechanism
- (2010) Soon Young Park et al. INTERNATIONAL JOURNAL OF CANCER
- Mitochondrial damage-induced impairment of angiogenesis in the aging rat kidney
- (2010) Minoru Satoh et al. LABORATORY INVESTIGATION
- R0 resection in the treatment of gastric cancer: Room for improvement
- (2010) Alberto Biondi WORLD JOURNAL OF GASTROENTEROLOGY
- The role of the Angiopoietins in vascular morphogenesis
- (2009) Markus Thomas et al. ANGIOGENESIS
- Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes
- (2009) C Alfaro et al. BRITISH JOURNAL OF CANCER
- PDGF-C Mediates the Angiogenic and Tumorigenic Properties of Fibroblasts Associated with Tumors Refractory to Anti-VEGF Treatment
- (2009) Yongping Crawford et al. CANCER CELL
- Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study
- (2009) Christopher G. Willett et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
- (2009) Scott Kopetz et al. JOURNAL OF CLINICAL ONCOLOGY
- Nicotinic receptor-associated modulation of stimulatory and inhibitory neurotransmitters in NNK-induced adenocarcinoma of the lungs and pancreas
- (2009) Hussein AN Al-Wadei et al. JOURNAL OF PATHOLOGY
- Propranolol for Severe Infantile Hemangiomas: Follow-Up Report
- (2009) V. Sans et al. PEDIATRICS
- Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation
- (2009) C. Therapontos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Social isolation dysregulates endocrine and behavioral stress while increasing malignant burden of spontaneous mammary tumors
- (2009) Gretchen L. Hermes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumor–stroma co-evolution in prostate cancer progression and metastasis
- (2009) Sajni Josson et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Thrombospondins function as regulators of angiogenesis
- (2009) Paul Bornstein Journal of Cell Communication and Signaling
- p53 hot-spot mutants increase tumor vascularization via ROS-mediated activation of the HIF1/VEGF-A pathway
- (2008) N.V. Khromova et al. CANCER LETTERS
- Randomized, Phase II Study of the Thrombospondin-1-Mimetic Angiogenesis Inhibitor ABT-510 in Patients With Advanced Soft Tissue Sarcoma
- (2008) Laurence H. Baker et al. JOURNAL OF CLINICAL ONCOLOGY
- Antitumor Activity and Biomarker Analysis of Sunitinib in Patients With Bevacizumab-Refractory Metastatic Renal Cell Carcinoma
- (2008) Brian I. Rini et al. JOURNAL OF CLINICAL ONCOLOGY
- R Regulation of tumor angiogenesis and metastasis by FGF and PDGF signaling pathways
- (2008) Yihai Cao et al. JOURNAL OF MOLECULAR MEDICINE-JMM
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search